About Vessix Vascular
Vessix Vascular is a Healthcare company based in Laguna Hills (United States) founded in 2003, and was acquired by Boston Scientific in November 2012. Thermoplasty technology for occlusive peripheral vascular diseases is developed. Vessix Vascular has raised $27.7 million across 2 funding rounds from investors including Boston Scientific, Orbimed and Rothschild. The company has 10 employees. Its focus areas include Life Sciences, Cardiac and Vascular Disorders, Medical Devices and Therapeutic Devices. Its legal entity is VESSIX VASCULAR INC. Its competitors include ReCor Medical, Ablative Solutions and Kona Medical; 3 of its 3 listed competitors have raised funding.
Company details
Vessix Vascular was established in 2003 in Laguna Hills, United States, within the medical device sector. Catheter-based systems for hypertension treatment are developed and manufactured. The ZCath System, featuring a low-pressure angioplasty catheter with radiofrequency electrodes, is utilized for endovascular procedures. Radiofrequency balloon catheters for renal denervation are also produced to manage hypertension. Operations center on thermoplasty applications for peripheral artery and vein occlusions.
- Headquarters Laguna Hills, United States
- Employees 10
- Stage Acquired
- SectorsHealthcare
- Website vessixvascular.com
- Social LinkedIn
- Acquired by Boston Scientific (Nov 2012)
- Legal Name Vessix Vascular Inc
- Total Equity Funding$27.7M (USD)
in 2 rounds
- Latest Funding Round$23M (USD), Series B
Aug 2011
- InvestorsBoston Scientific
& 5 more
- Employee Count10
- Acquired byBoston Scientific
(Nov 2012)
Funding Insights of Vessix Vascular
Vessix Vascular has successfully raised a total of $27.7M across 2 strategic funding rounds. The most recent funding activity was a Series B round of $23 million completed in August 2011. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $27.7M
- Total Rounds 2
- Last Round Series B — $23M
- First Round $4.7M
(Oct 2010)
- Investors Count 5
All 2 funding rounds of Vessix Vascular with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Aug 2011 | $23M | Series B | – | – | |
| Oct 2010 | $4.7M | Series A | – | – |
6 investors in total: 6 institutional.
Investors in Vessix Vascular
Vessix Vascular has secured backing from 6 investors, including institutional and venture fund investors. Prominent investors backing the company include Boston Scientific, Orbimed and Rothschild.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Investments are made by OrbiMed in global healthcare innovations across biopharmaceuticals and related fields. | 1989 | orbimed.com | New York, United States | |
Stage-agnostic life sciences-focused VC firm investing in North America & Europe | neomed.net | Oslo, Norway | ||
Risk capital is invested in growth companies in Western Norway. | fjordinvest.no | Førde, Norway | ||
DNV Capital is engaged in asset management for healthcare and technology industries. | dinovacapital.com | Shenzhen, China | ||
Global investment banking services are provided worldwide. | 1811 | rothschild.com | Paris, France | |
Wide range of medical devices | 1979 | bostonscientific.com | Marlborough, United States |
Investor details for Vessix Vascular
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Vessix Vascular
4 dated milestones of Vessix Vascular across 9 years, from founding to its latest funding, stage changes and deals.
- Founded Vessix Vascular is founded.
- Funding First funding round of $4.7M.
- Funding Latest funding round, Series B, of $23.0M.
- Exit Acquired by Boston Scientific.
Competitors of Vessix Vascular
Vessix Vascular has 3 listed competitors in our database, 3 of them funded. They include ReCor Medical, Ablative Solutions and Kona Medical.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| recormedical.com | 2009 | Palo Alto, United States | $15M | 93 | Ultrasound-based renal denervation is applied for hypertension treatment. | |
| ablativesolutions.com | 2011 | Kalamazoo, United States | $293.24M | 24 | A catheter-based renal denervation system for hypertension treatment is developed. | |
| konamedical.com | 2009 | Issaquah, United States | $73.66M | 39 | Provides ultrasound-based renal denervation solutions for hypertension treatment. |
Detailed competitors of Vessix Vascular
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Cardiac and Vascular Disorders
3 companies that operate in the same segment as Vessix Vascular (Cardiac and Vascular Disorders) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Gene-editing therapies for coronary artery disease are developed. | 2018 | Cambridge, Massachusetts, United States | USD 215.5 M | 255 | ||
Cardiac monitoring devices and applications are provided for heart health. | 2010 | Mountain View, California, United States | USD 114.38 M | USD 6.18 M | 67 | |
Therapies for lowering low-density lipoprotein cholesterol levels are developed. | 1998 | Ann Arbor, Michigan, United States | USD 129.7 M | USD 332.31 M | 304 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Vessix Vascular
Complete news archive for Vessix Vascular
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Vessix Vascular
Vessix Vascular was founded in 2003 and raised its 1st funding round 7 years after it was founded.
Vessix Vascular is headquartered in Laguna Hills, United States. It is registered at Laguna Hills, California, United States.
Vessix Vascular is a funded company, having raised a total of $27.7M across 2 funding rounds to date. The company's 1st funding round was a Series A of $4.7M, raised on Oct 2010.
Vessix Vascular has 10 employees.
Vessix Vascular was established in 2003 in Laguna Hills, United States, within the medical device sector. Catheter-based systems for hypertension treatment are developed and manufactured. The ZCath System, featuring a low-pressure angioplasty catheter with radiofrequency electrodes, is utilized for endovascular procedures. Radiofrequency balloon catheters for renal denervation are also produced to manage hypertension. Operations center on thermoplasty applications for peripheral artery and vein occlusions.
Vessix Vascular's top competitors include ReCor Medical, Ablative Solutions and Kona Medical.
Vessix Vascular has 6 investors. Key investors include Boston Scientific, Orbimed, Rothschild, NeoMed, and Fjord Invest.
Vessix Vascular operates through Vessix Vascular Inc.
Yes. Vessix Vascular was acquired by Boston Scientific in November 2012.